Hpv vaccine research paper

Both the increase and the burden it imposes are widely recognized by thousands of parents and frontline professionals such as nurses and teachers.

Hpv vaccine research paper

Most people—about 9 in 10—will get an HPV infection at some point in their lives. HPV infections can cause health problems, including several kinds of cancer in both women and men. There are safe and effective vaccines recommended to prevent these health problems from happening.

Vaccines, like any medicine, can have side effects. Many people who get the HPV vaccine have no side effects at all. Some people report having very mild side effects, like a sore arm from the shot.

The most common side effects are usually mild. Pain, redness, or swelling in the arm where the shot was given Fever Nausea Muscle or joint pain Brief fainting spells and related symptoms such as jerking movements can happen after any medical procedure, including vaccination.

Sitting or lying down for about 15 minutes after a vaccination can help prevent fainting and injuries caused by falls. On very rare occasions, severe anaphylactic allergic reactions may occur after vaccination. CDC recommends that anyone starting the series before their 15th birthday receives two doses of HPV vaccine at least six months after the first dose.

Adolescents who receive their two doses less than five months apart will require a third dose of HPV vaccine. Teens and young adults who start the series at ages 15 through 26 years still need three doses three doses of HPV vaccine. Also, three doses are still recommended for people with certain immunocompromising conditions aged 9 through 26 years.

Hpv vaccine research paper

FDA approved Gardasil 9 for use in The safety of Gardasil 9 was studied in clinical trials with more than 15, participants before it was licensed and continues to be monitored. Gardasil 9 protects against HPV types 6, 11, 16, 18, 31, 33, 45, 52, and FDA approved Gardasil for use in The safety of Gardasil was studied in clinical trials with more than 29, participants before it was licensed and continues to be monitored.

Gardasil protects against HPV types 6, 11, 16, and Any problems detected with these vaccines will be reported to health officials, health care providers, and the public.

CDC uses three systems to monitor vaccine safety: The Vaccine Safety Datalink VSD — a collaboration between CDC and several health care organizations that allows ongoing monitoring and proactive searches of vaccine-related data.

Hpv vaccine research paper

The safety findings from these pre-licensure studies show it has a similar safety profile to Gardasil. The main findings from these studies are: The most common side effect reported was pain, swelling, and redness in the arm where the shot was given.

These mild side effects may occur more often after Gardasil 9 vaccination than after Gardasil. Women and girls who received Gardasil 9 reported higher rates of swelling and redness where the shot was given than those who received Gardasil.

Free Research Paper on HPV

Reports of swelling and redness also increased with each following dose for those receiving Gardasil 9. The most common adverse events reported were:Research on HPV Vaccination and Risk Behavior Picture 4.

Research on the relationship between Gardasil and sexual behavior is still in progress. In , Dr. Peter Aaby, Director of the Bandim Health Project, a demographic surveillance system (in Guinea-Bissau, West Africa), which is affiliated with the Statens Serum Institute, identified non-specific adverse vaccine effects which go beyond the specific protective effects of the targeted rutadeltambor.com noted that these non-specific effects can be beneficial or harmful.

HPV Vaccine Side Effects. The HPV vaccine is very safe, and it is effective at preventing HPV. Vaccines, like any medicine, can have side effects. A fact sheet about human papillomavirus (HPV) vaccines for the prevention of infection with certain types of HPV, which is the major cause of cervical cancer.

In a position paper, Sampson JN, et al. Evidence for single-dose protection by the bivalent HPV vaccine-Review of the Costa Rica HPV vaccine trial and future research studies.

Aids Vaccine Research - GeoVax, Inc. GeoVax is a clinical-stage biotechnology company developing innovative human vaccines using novel Modified Vaccinia Ankara (MVA) Virus-Like Particle (VLP) platform technology.

Hpv vaccine research paper Hpv vaccine research paper engineers ireland chartership essays online biology unit 5 essay calendar extended essay breakdown insurance essay on uses of science in everyday life golconda fort short essay about nature death of a salesman well liked essay short essay on microorganisms ppt custom essay online edit.

WHO | Vaccine Position Papers